Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG240038 Inhibitors

EG240038 inhibitors are a class of chemical compounds designed to specifically block the activity of **EG240038**, a molecular target whose function is believed to be integral to various cellular processes such as protein interaction, signal transduction, or enzymatic regulation. EG240038, like many molecular entities, may play a pivotal role in maintaining cellular homeostasis by facilitating or regulating key pathways within the cell. Inhibitors of EG240038 operate by binding to its active site or interacting with regions critical for its function, thereby preventing it from executing its biological role. This interference allows researchers to explore the biochemical pathways in which EG240038 is involved and to understand how the inhibition of this target affects the dynamics of cellular function.

The use of EG240038 inhibitors is essential for studying the broader impact of this molecule's activity on cellular networks. By inhibiting EG240038, researchers can observe downstream changes in molecular interactions, protein folding, or metabolic processes, providing a deeper understanding of its role in these complex systems. These inhibitors also help identify how EG240038 interacts with other cellular components, such as enzymes or signaling proteins, revealing its involvement in maintaining the balance of various cellular functions. The detailed investigation into EG240038 inhibition contributes to a comprehensive understanding of how cells regulate key processes, such as energy metabolism, protein synthesis, or intracellular signaling. By disrupting its activity, researchers can map out the molecular interactions and regulatory feedback loops that depend on EG240038, enhancing our knowledge of the intricate web of cellular activities and molecular communications.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

DNA intercalating agent inhibiting transcription. Directly inhibits Zfp994 by preventing RNA polymerase II from transcribing target genes, disrupting its DNA-binding activity.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Inhibitor of transcription factor IIH (TFIIH). Indirectly affects Zfp994 by interfering with the initiation of transcription, potentially impacting its cis-regulatory region sequence-specific DNA binding activity.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$254.00
41
(3)

Cyclin-dependent kinase (CDK) inhibitor. Indirectly influences Zfp994 by inhibiting CDK9, a key regulator of RNA polymerase II-mediated transcription, potentially affecting its activity and DNA binding.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

RNA polymerase II inhibitor. Directly inhibits Zfp994 by preventing RNA polymerase II-mediated transcription, impacting its RNA polymerase II-specific DNA binding activity.

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

Bromodomain and extraterminal (BET) inhibitor. Indirectly influences Zfp994 by targeting bromodomains, potentially affecting chromatin accessibility and cis-regulatory region sequence-specific DNA binding.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

CDK9 inhibitor. Indirectly affects Zfp994 by inhibiting CDK9, potentially impacting its RNA polymerase II-specific DNA binding activity and transcriptional regulation.

Fludarabine

21679-14-1sc-204755
sc-204755A
5 mg
25 mg
$57.00
$200.00
15
(1)

DNA synthesis inhibitor. Indirectly influences Zfp994 by affecting general transcription processes, potentially altering RNA polymerase II-mediated transcription and its DNA-binding activity.

C646

328968-36-1sc-364452
sc-364452A
10 mg
50 mg
$260.00
$925.00
5
(1)

Histone acetyltransferase (HAT) inhibitor. Indirectly influences Zfp994 by inhibiting p300/CBP-associated factor (PCAF), potentially affecting chromatin acetylation and cis-regulatory region sequence-specific DNA binding.